Skip to main content

Day: April 2, 2020

SORRENTO TO PROVIDE MANUFACTURING SUPPORT TO CELULARITY AS CYNK-001 NK CELL TRIAL FOR COVID-19 BEGINS ENROLLING PATIENTS

SAN DIEGO, April 02, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced it has initiated the next phase of its collaboration with Celularity, Inc., a Warren, New Jersey, based clinical-stage cell therapeutics company delivering transformative allogeneic cellular therapies derived from the postpartum human placenta. On April 2, 2020, Celularity announced that the U.S. Food and Drug Administration (FDA) cleared its Investigational New Drug (IND) application for the use of its proprietary CYNK-001 in adults with COVID-19. Celularity also announced that it will immediately commence a Phase I/II clinical study including up to 86 patients with COVID-19.The collaboration between Sorrento and Celularity reflects the longstanding relationship between the two companies dating to Celularity’s...

Continue reading

Meddelelse nr. 4: Indkaldelse til ordinær generalforsamling 27. april 2020

Dato: 02.04.2020Årets meddelelse nr.: 4Indkaldelse til ordinær generalforsamling i Blue Vision A/S mandag den 27. april 2020, kl. 10.00 hos Contra A/S, Vester Farimagsgade 1, 2., 1668 København V.   Som følge af regeringens og Sundhedsstyrelsens påbud, retningslinjer og anbefalinger om øget smittefare skal vi indtrængende opfordre til at undlade deltagelse i dette års generalforsamling. Vi vil samtidig benytte lejligheden til at opfordre aktionærerne til at give fuldmagt til bestyrelsen som nærmere beskrevet nedenfor.Dagsordenen er følgende:1. Præsentation af dirigent2. Bestyrelsens beretning om selskabets virksomhed i det forløbne år3. Fremlæggelse af revideret årsrapport til godkendelse og meddelelse af decharge for bestyrelse og direktion4. Vedtagelse af fordeling af overskud eller underskud efter forslag fra bestyrelsen5. Valg af...

Continue reading

Landsvirkjun‘s Home Member State

According to paragraph 7 of article 3 of the Icelandic Act no. 108/2007 on Securities Transactions issuers whose securities are admitted to trading on a regulated market are required to disclose their choice of home member state. In accordance with that it is made known that Iceland is Landsvirkjun’s home member state according to paragraph 3 of article 3 of the Icelandic Act No. 108/2007 on Securities Transactions, cf. article 2 (1) (i) (ii) of Directive 2004/109/EC of the European Parliament and the Council of 15 December 2004 on the harmonisation of transparency requirements in relation to information about issuers whose securities are admitted to trading on a regulated market and amending Directive 2001/34/EC.Reykjavik, 2 April 2020For further information please contact Rafnar Lárusson, CFO at +354 515 9000 or by email: rafnar.la...

Continue reading

Heimaríki Landsvirkjunar

Í 7.mgr. 3 gr. laga nr. 108/2007 um verðbréfaviðskipti er kveðið á um að útgefandi verðbréfa á skipulegum verðbréfamarkaði skuli birta val á heimaríki skv. 3 mgr. 3. gr. opinberlega. Í samræmi við það tilkynnist að Ísland er heimaríki Landsvirkjunar samkvæmt 3. mgr. 3. gr. laga nr. 108/2007 um verðbréfaviðskipti, sbr. ii) lið, i) liðar, 1. mgr. 2. gr. tilskipunar Evrópuþingsins og Ráðsins 2004/109/EB frá 15. desember 2004, um samhæfingu krafna um gagnsæi í tengslum við upplýsingar um útgefendur verðbréfa sem eru skráð á skipulegan markað og um breytingu á tilskipun 2001/34/EB.Reykjavík, 2. apríl, 2020Nánari upplýsingar veitir Rafnar Lárusson, framkvæmdastjóri fjármálasviðs.Sími 515 9000, netfang: rafnar.larusson@landsvirkjun.is

Continue reading

Norsk Hydro: Hydro takes action to strengthen robustness amid Covid-19

The Covid-19 situation is a challenge to the global economy and continues to cause significant uncertainty for Hydro’s operations and business areas. Hydro is taking firm measures to ensure a safe work environment, contribute to communities, maintain operations and safeguard liquidity, including amending previously communicated dividend proposal and implementing capex freeze.“Our top priority is the health and safety of our people and the communities where we operate. With forceful mitigating actions and contingency plans across the company, we will continue operations to the extent possible, keeping the wheels turning, to the benefit of our people, our business, local communities and society at large,” says President and CEO Hilde Merete Aasheim.“We will continuously evaluate further measures as the situation develops,” Aasheim...

Continue reading

Norsk Hydro: Hydro iverksetter tiltak for å styrke robustheten i Covid-19-situasjonen

Covid-19 situasjonen er utfordrende for den globale økonomien og fortsetter å bidra til betydelig usikkerhet for Hydros virksomhet og forretningsområder. Hydro tar grep for å sikre et trygt arbeidsmiljø, støtte lokalsamfunn, opprettholde virksomhet og sikre likviditet. Tiltakene omfatter endring av tidligere annonsert utbyttebeslutning og frys av investeringer. – Helsen og sikkerheten til våre ansatte og lokalsamfunnene hvor vi har virksomhet er vår viktigste prioritet. Med kraftfulle avbøtende tiltak og beredskapsplaner på tvers av selskapet vil vi fortsette våre operasjoner så langt det er mulig, til fordel våre ansatte, vår virksomhet, lokalsamfunn og samfunnet for øvrig, sier konsernsjef Hilde Merete Aasheim.Nåværende tiltak inkluderer:Midlertidig reduksjon og oppsigelserHydro fryser 25% av gjenværende 2020 investeringerUtsettelse...

Continue reading

Brøndbyernes IF Fodbold A/S – Forløb af ordinær generalforsamling

BRØNDBYERNES I.F. FODBOLD A/SCVR-nr. 83 93 34 10Brøndby, den 2. april 2020SELSKABSMEDDELELSE NR. 12/2020  Brøndbyernes IF Fodbold A/S – Forløb af ordinær generalforsamlingDen 2. april 2020, kl. 17.30, blev der afholdt ordinær generalforsamling i Brøndbyernes IF Fodbold A/S på selskabets adresse, Brøndby Stadion 28, 2605 Brøndby.Dagsordenen var som følger:Forelæggelse af årsrapport med revisionspåtegning til godkendelse samt årsberetning.Forslag til anvendelse af overskud eller dækning af tab i henhold til den godkendte årsrapport.Godkendelse af bestyrelsens vederlag for det igangværende regnskabsår.Forslag fra bestyrelsen.Bestyrelsen foreslår, at vedtægternes § 3a ophæves og erstattes af en ny § 3a.Der stilles således forslag om, at § 3a bliver sålydende:”Bestyrelsen er indtil 2. april 2025 bemyndiget til at beslutte at forhøje Selskabets...

Continue reading

COFACE SA : Déclaration du nombre total des droits de vote et du nombre d’actions composant le capital social au 31 mars 2020

Paris, le 2 avril 2020 – 17h45                                                    COFACE SA : Déclaration du nombre total des droits de vote et du nombre d’actions composant le capital social au 31 mars 2020y compris actions auto-détenuesdéduction faite des actions auto-détenuesLe document du mois de février comportait une erreur. Le nombre de droits de vote exerçables était de 151 215 244.Pièce jointe2020 03 31 Declaration Actions&Droits de Vote FR

Continue reading

Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2020

Communiqué de presseInformation relative au nombre total de droits de vote et d’actions composant le capital social établie conformément aux dispositions de l’article L. 233-8 II du code de commerce et de l’article 223-16 du Règlement général de l’AMFDéclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2020La Motte-Fanjas, le 2 avril 2020 – 17h45 CEST – McPhy (Euronext Paris Compartiment C : MCPHY, FR0011742329) spécialiste des équipements de production et distribution d’hydrogène, annonce aujourd’hui la déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2020.Société déclarante Dénomination sociale : McPhy Energy S.A. Siège social : 1115 route de Saint-Thomas – 26190 La Motte-Fanjas Immatriculée sous le n° 502 205 917 R.C.S. Romans Euronext Paris Compartiment C (Code ISIN : FR0011742329...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.